48,830
edits
Difference between revisions of "Parathyroid carcinoma"
Jump to navigation
Jump to search
→IHC
(+infobox) |
(→IHC) |
||
| Line 69: | Line 69: | ||
*Ki-67 >6% of cells positive - supports diagnosis.<ref name=pmid7860042>{{Cite journal | last1 = Abbona | first1 = GC. | last2 = Papotti | first2 = M. | last3 = Gasparri | first3 = G. | last4 = Bussolati | first4 = G. | title = Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining. | journal = Hum Pathol | volume = 26 | issue = 2 | pages = 135-8 | month = Feb | year = 1995 | doi = | PMID = 7860042 }}</ref> | *Ki-67 >6% of cells positive - supports diagnosis.<ref name=pmid7860042>{{Cite journal | last1 = Abbona | first1 = GC. | last2 = Papotti | first2 = M. | last3 = Gasparri | first3 = G. | last4 = Bussolati | first4 = G. | title = Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining. | journal = Hum Pathol | volume = 26 | issue = 2 | pages = 135-8 | month = Feb | year = 1995 | doi = | PMID = 7860042 }}</ref> | ||
**Parathyroid adenomas and hyperplasias ~ 3%. | **Parathyroid adenomas and hyperplasias ~ 3%. | ||
*[[PAX8]] +ve.<ref name=pmid22498579>{{Cite journal | last1 = Ordóñez | first1 = NG. | title = Value of PAX 8 immunostaining in tumor diagnosis: a review and update. | journal = Adv Anat Pathol | volume = 19 | issue = 3 | pages = 140-51 | month = May | year = 2012 | doi = 10.1097/PAP.0b013e318253465d | PMID = 22498579 }}</ref> | |||
==See also== | ==See also== | ||